20+ years of progressive global leadership and board experience developing and executing strategy, building and leading commercial, operational, finance, and human capital functions. Success across divisions, segments, businesses, regions, and enterprise-wide resulting in increased market share and strong results growing revenue and profit margins. Proven global operator with: full P&L ownership from launch to $600M; success scaling (2 startup exits: $4.3B IPO and $350M strategic acquisition); worldwide launches (15+ Class II/III, incl. 3 Breakthrough); leading product dev & innovation strategy (11 patents/pending); and executing M&A transactions/integrations ($12B, $350M, $94M, $80M deals). Success building and leading on-site and virtual teams while physically located across multiple U.S. states, Latin America, and China. Experienced influencing critical executive decision-making in startups, regional enterprises, and Fortune 500 global matrix orgs. Board leadership experience (3 startup and 3 non-profit) and startup advisory (venture capital LP and angel investor). Led commercialization for the first two software FDA Breakthrough devices approved.Developed, launched, and grew: - AI / machine learning and augmented reality solutions; - IoT solutions;- Regulated and non-regulated software, incl. software as medical device (SAMD);- Healthcare solutions (therapeutics, diagnostics, imaging and sequencing CDx, implantables, consumables) in immuno-oncology, genomics (NGS), women’s health, pulmonology, hematology, infectious disease, autoimmune, and other disease states. MBA Global Strategy, Marketing from Darden GSB (University of Virginia). MBA studies at Peking University, Guanghua School of Management (北京大学光华管理学院).B.S. Biology from Brigham Young University. Other university studies in: genetics, human physiology, computer engineering, law, China business. 11 patents and pending.English (Native); Spanish (Fluent); Mandarin (Basic); French (Learning)